Key result
Cardiac fibrosis is a chronic inflammatory process and a promising therapeutic target for managing cardiac hypertrophy, heart failure, and lethal arrhythmias.
Key points are not available for this paper at this time.
Design
Review
Cardiac fibrosis is highlighted as a chronic inflammatory condition and a promising therapeutic target for managing cardiac hypertrophy, heart failure, and arrhythmias.
A better understanding on the cause, pathophysiologic mechanisms and potential new treatments of cardiac fibrosis is one of the main issues in the management of cardiac hypertrophy, heart failure and lethal arrhythmia [...].
No takes yet. Share an insight, caveat, or question.
Ryuji Okamoto (2022) studied this question. Cardiac fibrosis is a chronic inflammatory process and a promising therapeutic target for managing cardiac hypertrophy, heart failure, and lethal arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: